Tagata, Rey John N.
HRN: 28-23-42 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
CEFUROXIME 750MG (VIAL)
12/09/2025
12/16/2025
IV
315mg
Q8hours
PCAP-C
Checking Final Appropriateness